175 related articles for article (PubMed ID: 11697627)
1. Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
Kawasaki C; Ohshim K; Suzumiya J; Kanda M; Tsuchiya T; Tamura K; Kikuchi M
Leuk Lymphoma; 2001; 42(5):1099-106. PubMed ID: 11697627
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas.
Pescarmona E; De Sanctis V; Pistilli A; Pacchiarotti A; Martelli M; Guglielmi C; Mandelli F; Baroni CD; Le Coco F
J Pathol; 1997 Nov; 183(3):281-6. PubMed ID: 9422982
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Bcl 10 rearrangement in diffuse large B-cell lymphoma.
Kawasaki C; Ohshima K; Muta H; Muta K; Deyev V; Podack ER; Kikuchi M
Leuk Lymphoma; 2002 Apr; 43(4):823-6. PubMed ID: 12153171
[TBL] [Abstract][Full Text] [Related]
5. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
7. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
[TBL] [Abstract][Full Text] [Related]
8. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
9. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.
Offit K; Lo Coco F; Louie DC; Parsa NZ; Leung D; Portlock C; Ye BH; Lista F; Filippa DA; Rosenbaum A
N Engl J Med; 1994 Jul; 331(2):74-80. PubMed ID: 8208268
[TBL] [Abstract][Full Text] [Related]
11. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients.
Vitolo U; Gaidano G; Botto B; Volpe G; Audisio E; Bertini M; Calvi R; Freilone R; Novero D; Orsucci L; Pastore C; Capello D; Parvis G; Sacco C; Zagonel V; Carbone A; Mazza U; Palestro G; Saglio G; Resegotti L
Ann Oncol; 1998 Jan; 9(1):55-61. PubMed ID: 9541684
[TBL] [Abstract][Full Text] [Related]
12. BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
Butler M; Corbally N; Dervan PA; Carney DN
Br J Cancer; 1997; 75(11):1641-5. PubMed ID: 9184180
[TBL] [Abstract][Full Text] [Related]
13. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
[TBL] [Abstract][Full Text] [Related]
15. Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Ueda C; Nishikori M; Kitawaki T; Uchiyama T; Ohno H
Int J Hematol; 2004 Jan; 79(1):52-4. PubMed ID: 14979479
[TBL] [Abstract][Full Text] [Related]
16. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
[TBL] [Abstract][Full Text] [Related]
17. Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Kondo E; Yoshino T; Akagi T; Hayashi K; Takahashi K
Acta Med Okayama; 1992 Dec; 46(6):407-15. PubMed ID: 1485535
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
Volpe G; Vitolo U; Carbone A; Pastore C; Bertini M; Botto B; Audisio E; Freilone R; Novero D; Cappia S; De Giuli P; Mazza U; Resegotti L; Palestro G; Saglio G; Gaidano G
Genes Chromosomes Cancer; 1996 May; 16(1):21-30. PubMed ID: 9162193
[TBL] [Abstract][Full Text] [Related]
19. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab.
Akyurek N; Uner A; Benekli M; Barista I
Cancer; 2012 Sep; 118(17):4173-83. PubMed ID: 22213394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]